Small Company, Big Drug

genomeweb
360dx

Small Company, Big Drug

Feb 08, 2007

Will biotech “castoffs” develop the next blockbuster drugs?, asks a recent Wall Street Journal article ($).

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

Diagnomics Teams With Fabric Genomics on ACMG-59 Report
UK Biobank Dataset Helps Elucidate Pathogenicity of Rare Genetic Variants
Large Human Microbiome Analysis Discovers Thousands of New Species
BD Preliminary Fiscal Q1 Revenues Up 35 Percent on Continued Bard Boost
Wheat Blast Genomic Analyses Highlighted at PAG
Qiagen EGFR Assay Approved in Japan as CDx to Pfizer NSCLC Drug

The Scan

More Common Than Thought

An analysis of UK Biobank data finds hemochromatosis to be more prevalent than thought, according to the BBC.

Even for Prizes, Women Get Less Money

An analysis finds that female biomedical researchers receive fewer prizes than male ones, and when they do win prizes, they are less prestigious.

This Week in Nature

In Nature this week: improved genomic analysis using a graph genome reference, tumor mutational burden could predict clinical response to immune checkpoint inhibitors, and more.

Scramble to Keep the Work Alive

Federal researchers tell the Los Angeles Times that the shutdown is causing missed research opportunities as they try to keep their experiments going.

Main menu